PGx101 Learning Objectives

Learning Objectives

The pharmacist who completes the home-study and live components of this Pharmacogenomics Certificate Program should be able to:

1. Understand principles and foundational knowledge of pharmacogenomics, including its role in precision medicine.
2. Identify genetic variants that influence drug metabolism, efficacy, and toxicity.
3. Explore drug-gene interactions that impact drug absorption, distribution, metabolism, and excretion (ADME).
4. Develop skills in interpreting laboratory reports and genetic test results to guide clinical decision-making.
5. Demonstrate how to incorporate pharmacogenomic insights into patient care to optimize
   therapeutic outcomes.
6. Understand regulatory and ethical considerations and address the ethical, legal, social, and
   regulatory implications of pharmacogenomic testing and personalized medicine.
7. Utilize patient-centered communication focused on pharmacogenomic information effectively
   to patients and other healthcare professionals.
8. Evaluate evidence-based resources that are used to access, evaluate, and apply pharmacogenomic literature and guidelines in clinical practice.
9. Apply pharmacogenomics in special populations taking into consideration age, ethnicity, and comorbidities.
10. Use real-world scenarios to practice applying pharmacogenomic knowledge to patient care, with
    a focus on specific medications for cardiology, immunology, neurology, psychiatry, and rheumatology/musculoskeletal conditions.
11. Understand laboratory techniques and laboratory methods used in pharmacogenomics, such as
    genotyping and sequencing.
12. Develop collaborative skills and promote interdisciplinary collaboration between pharmacists, geneticists, and other healthcare providers.
13. Implement clinical decision support tools using electronic health records that incorporate pharmacogenomic data.
14. Assess cost-effectiveness of pharmacogenomics and explore the economic implications of
    pharmacogenomics, including cost-benefit analyses for healthcare systems.
15. Be prepared to discuss ways to engage in clinical research or quality improvement projects to
    further the field of pharmacogenomics.